In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  midazolam hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 21
Sponsor: Other
Protocol IDs: PK01/16/08, NCT00808184

2.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 20110920A, NCT01499836

3.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-88143, NCI-V89-0039

4.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-07-C-0047, NCI-P6880, NCT00436735

5.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: NP22676, NCT01001299

6.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-044, 2010_511, NCT01071304

7.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02916, CDR0000685426, CO09908, 8516, U01CA062491, P30CA014520, WCCC-CO-09908, NCT01218620

8.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAMN107A2128, 2009-009425-28, NCT01223898

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12434, NCT01287598

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U158, NCT01517399

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: INT12497, U1111-1125-8930, NCT01585623

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTKI258A2119, 2011-001489-16, NCT01596647

13.

Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-89098, NCI-V89-0193

14.

Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-000848, NCT00578214

15.

Phase: No phase specified
Type: Health services research, Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Other
Protocol IDs: 4-2012-0661, NCT01806753

16.

Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 20 to 65
Sponsor: Other
Protocol IDs: 4-2013-0444, NCT01945476

17.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 40 to 80
Sponsor: Other
Protocol IDs: 550, NCT01998685
New Search